 | • レポートコード：MR2211MG10855 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、調剤・新規薬物伝達システムのグローバル市場規模と予測を記載しています。・調剤・新規薬物伝達システムのグローバル市場：売上、2017年-2022年、2023年-2028年 ・調剤・新規薬物伝達システムのグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 調剤・新規薬物伝達システムのグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「リポソーム」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 調剤・新規薬物伝達システムのグローバル主要企業は、Amgen、Teva、Roche、UCB (Union Chimique Belge)、Celgene、Merck、Gilead Sciences、Sanofi、Pfizer、Takeda、Bausch&Lomb、Samyang Biopharmaceuticals、Johnson & Johnson、TOLMAR、Astellas、AMAG Pharmaceuticals、AbbVie、Dr Reddy、AstraZeneca、Aspen、Acrotech Biopharma、TWi Pharmaceuticalsなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、調剤・新規薬物伝達システムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の調剤・新規薬物伝達システム市場：タイプ別、2017年-2022年、2023年-2028年 世界の調剤・新規薬物伝達システム市場：タイプ別市場シェア、2021年 ・リポソーム、PEG化タンパク質・ポリペプチド、高分子ナノ粒子、タンパク質ｰ薬物複合体、その他 世界の調剤・新規薬物伝達システム市場：用途別、2017年-2022年、2023年-2028年 世界の調剤・新規薬物伝達システム市場：用途別市場シェア、2021年 ・病院・クリニック、がん治療センター、その他 世界の調剤・新規薬物伝達システム市場：地域・国別、2017年-2022年、2023年-2028年 世界の調剤・新規薬物伝達システム市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における調剤・新規薬物伝達システムのグローバル売上、2017年-2022年 ・主要企業における調剤・新規薬物伝達システムのグローバル売上シェア、2021年 ・主要企業における調剤・新規薬物伝達システムのグローバル販売量、2017年-2022年 ・主要企業における調剤・新規薬物伝達システムのグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Amgen、Teva、Roche、UCB (Union Chimique Belge)、Celgene、Merck、Gilead Sciences、Sanofi、Pfizer、Takeda、Bausch&Lomb、Samyang Biopharmaceuticals、Johnson & Johnson、TOLMAR、Astellas、AMAG Pharmaceuticals、AbbVie、Dr Reddy、AstraZeneca、Aspen、Acrotech Biopharma、TWi Pharmaceuticals ************************************************************* ・調査・分析レポートの概要 調剤・新規薬物伝達システム市場の定義 市場セグメント 世界の調剤・新規薬物伝達システム市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の調剤・新規薬物伝達システム市場規模 世界の調剤・新規薬物伝達システム市場規模：2021年 VS 2028年 世界の調剤・新規薬物伝達システム市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの調剤・新規薬物伝達システムの売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の調剤・新規薬物伝達システム製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：リポソーム、PEG化タンパク質・ポリペプチド、高分子ナノ粒子、タンパク質ｰ薬物複合体、その他 調剤・新規薬物伝達システムのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院・クリニック、がん治療センター、その他 調剤・新規薬物伝達システムの用途別グローバル売上・予測 ・地域別市場分析 地域別調剤・新規薬物伝達システム市場規模 2021年と2028年 地域別調剤・新規薬物伝達システム売上・予測 北米市場 - アメリカの調剤・新規薬物伝達システム市場規模2017年-2028年 - カナダの調剤・新規薬物伝達システム市場規模2017年-2028年 - メキシコの調剤・新規薬物伝達システム市場規模2017年-2028年 ヨーロッパ市場 - ドイツの調剤・新規薬物伝達システム市場規模2017年-2028年 - フランスの調剤・新規薬物伝達システム市場規模2017年-2028年 - イギリスの調剤・新規薬物伝達システム市場規模2017年-2028年 - イタリアの調剤・新規薬物伝達システム市場規模2017年-2028年 - ロシアの調剤・新規薬物伝達システム市場規模2017年-2028年 アジア市場 - 中国の調剤・新規薬物伝達システム市場規模2017年-2028年 - 日本の調剤・新規薬物伝達システム市場規模2017年-2028年 - 韓国の調剤・新規薬物伝達システム市場規模2017年-2028年 - 東南アジアの調剤・新規薬物伝達システム市場規模2017年-2028年 - インドの調剤・新規薬物伝達システム市場規模2017年-2028年 南米市場 - ブラジルの調剤・新規薬物伝達システム市場規模2017年-2028年 - アルゼンチンの調剤・新規薬物伝達システム市場規模2017年-2028年 中東・アフリカ市場 - トルコの調剤・新規薬物伝達システム市場規模2017年-2028年 - イスラエルの調剤・新規薬物伝達システム市場規模2017年-2028年 - サウジアラビアの調剤・新規薬物伝達システム市場規模2017年-2028年 - UAEの調剤・新規薬物伝達システム市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Amgen、Teva、Roche、UCB (Union Chimique Belge)、Celgene、Merck、Gilead Sciences、Sanofi、Pfizer、Takeda、Bausch&Lomb、Samyang Biopharmaceuticals、Johnson & Johnson、TOLMAR、Astellas、AMAG Pharmaceuticals、AbbVie、Dr Reddy、AstraZeneca、Aspen、Acrotech Biopharma、TWi Pharmaceuticals ... |
Novel drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.
This report contains market size and forecasts of Pharmaceutics and Novel Drug Delivery Systems in Global, including the following market information:
Global Pharmaceutics and Novel Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceutics and Novel Drug Delivery Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutics and Novel Drug Delivery Systems include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutics and Novel Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutics and Novel Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Other
Global Pharmaceutics and Novel Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
Hospitals & Clinic
Cancer Treatment Centers
Others
Global Pharmaceutics and Novel Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutics and Novel Drug Delivery Systems revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceutics and Novel Drug Delivery Systems revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
1 Introduction to Research & Analysis Reports
1.1 Pharmaceutics and Novel Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutics and Novel Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutics and Novel Drug Delivery Systems Overall Market Size
2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size: 2021 VS 2028
2.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceutics and Novel Drug Delivery Systems Players in Global Market
3.2 Top Global Pharmaceutics and Novel Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutics and Novel Drug Delivery Systems Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmaceutics and Novel Drug Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutics and Novel Drug Delivery Systems Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutics and Novel Drug Delivery Systems Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutics and Novel Drug Delivery Systems Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Pharmaceutics and Novel Drug Delivery Systems Market Size Markets, 2021 & 2028
4.1.2 Liposomes
4.1.3 PEGylated Proteins & Polypeptides
4.1.4 Polymer Nanoparticle
4.1.5 Protein–drug Conjugates
4.1.6 Other
4.2 By Type – Global Pharmaceutics and Novel Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2022
4.2.2 By Type – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2023-2028
4.2.3 By Type – Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pharmaceutics and Novel Drug Delivery Systems Market Size, 2021 & 2028
5.1.2 Hospitals & Clinic
5.1.3 Cancer Treatment Centers
5.1.4 Others
5.2 By Application – Global Pharmaceutics and Novel Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2022
5.2.2 By Application – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2023-2028
5.2.3 By Application – Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Pharmaceutics and Novel Drug Delivery Systems Market Size, 2021 & 2028
6.2 By Region – Global Pharmaceutics and Novel Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2022
6.2.2 By Region – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2023-2028
6.2.3 By Region – Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.3.2 US Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.3.3 Canada Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.3.4 Mexico Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.4.2 Germany Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.3 France Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.4 U.K. Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.5 Italy Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.6 Russia Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.7 Nordic Countries Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.8 Benelux Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.5.2 China Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.3 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.4 South Korea Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.5 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.6 India Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.6.2 Brazil Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.6.3 Argentina Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.7.2 Turkey Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7.3 Israel Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7.4 Saudi Arabia Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7.5 UAE Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
7 Players Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.1.4 Amgen Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.1.5 Amgen Key News
7.2 Teva
7.2.1 Teva Corporate Summary
7.2.2 Teva Business Overview
7.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.2.4 Teva Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.2.5 Teva Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.3.4 Roche Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.3.5 Roche Key News
7.4 UCB (Union Chimique Belge)
7.4.1 UCB (Union Chimique Belge) Corporate Summary
7.4.2 UCB (Union Chimique Belge) Business Overview
7.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.4.4 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.4.5 UCB (Union Chimique Belge) Key News
7.5 Celgene
7.5.1 Celgene Corporate Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.5.4 Celgene Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.5.5 Celgene Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.6.4 Merck Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.6.5 Merck Key News
7.7 Gilead Sciences
7.7.1 Gilead Sciences Corporate Summary
7.7.2 Gilead Sciences Business Overview
7.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.7.4 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.7.5 Gilead Sciences Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.8.4 Sanofi Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.8.5 Sanofi Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.9.4 Pfizer Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Takeda
7.10.1 Takeda Corporate Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.10.4 Takeda Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.10.5 Takeda Key News
7.11 Bausch&Lomb
7.11.1 Bausch&Lomb Corporate Summary
7.11.2 Bausch&Lomb Business Overview
7.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.11.4 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.11.5 Bausch&Lomb Key News
7.12 Samyang Biopharmaceuticals
7.12.1 Samyang Biopharmaceuticals Corporate Summary
7.12.2 Samyang Biopharmaceuticals Business Overview
7.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.12.4 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.12.5 Samyang Biopharmaceuticals Key News
7.13 Johnson & Johnson
7.13.1 Johnson & Johnson Corporate Summary
7.13.2 Johnson & Johnson Business Overview
7.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.13.4 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.13.5 Johnson & Johnson Key News
7.14 TOLMAR
7.14.1 TOLMAR Corporate Summary
7.14.2 TOLMAR Business Overview
7.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.14.4 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.14.5 TOLMAR Key News
7.15 Astellas
7.15.1 Astellas Corporate Summary
7.15.2 Astellas Business Overview
7.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.15.4 Astellas Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.15.5 Astellas Key News
7.16 AMAG Pharmaceuticals
7.16.1 AMAG Pharmaceuticals Corporate Summary
7.16.2 AMAG Pharmaceuticals Business Overview
7.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.16.4 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.16.5 AMAG Pharmaceuticals Key News
7.17 AbbVie
7.17.1 AbbVie Corporate Summary
7.17.2 AbbVie Business Overview
7.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.17.4 AbbVie Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.17.5 AbbVie Key News
7.18 Dr Reddy
7.18.1 Dr Reddy Corporate Summary
7.18.2 Dr Reddy Business Overview
7.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.18.4 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.18.5 Dr Reddy Key News
7.19 AstraZeneca
7.19.1 AstraZeneca Corporate Summary
7.19.2 AstraZeneca Business Overview
7.19.3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.19.4 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.19.5 AstraZeneca Key News
7.20 Aspen
7.20.1 Aspen Corporate Summary
7.20.2 Aspen Business Overview
7.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.20.4 Aspen Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.20.5 Aspen Key News
7.21 Acrotech Biopharma
7.21.1 Acrotech Biopharma Corporate Summary
7.21.2 Acrotech Biopharma Business Overview
7.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.21.4 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.21.5 Acrotech Biopharma Key News
7.22 TWi Pharmaceuticals
7.22.1 TWi Pharmaceuticals Corporate Summary
7.22.2 TWi Pharmaceuticals Business Overview
7.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.22.4 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.22.5 TWi Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer